Diabetes, the pancreas and the liver

We know that the liver and pancreas can contribute to diabetes, but how significant is their role and what part does genomics play?
Adult holding baby's hand in hospital

NICE approves world-first MLD therapy

We explore a new gene therapy for a rare, fatal condition that affects young children
Render of inflamed tissue in the body

Lupus and the genome

A groundbreaking study has shed light on how some people may inherit autoimmune conditions
Render of a human brain with representation of activity

Understanding Alzheimer's

Modern advances in genomics are revealing new links between many of our genes and the chance of developing the condition
Render of Covid-19 virus cells and DNA helices

Covid-19 update: ‘problem’ variants found

New research shows that certain gene variants could be drivers for life-threatening Covid-19 illness
Points of blue and red light connected together

Diverse genomic study pinpoints Covid-19 variant

Sometimes data diversity can make the difference. We look at findings from a new Covid-19 study to find out how

Mystery variant doubles Covid-19 severity

But how was it found, and could it help open up new avenues for treatment?
Render of a DNA helix

BRCA: beyond breast cancer

New evidence shows that BRCA variants may increase the risk of stomach and pancreatic cancers in both men and women

Polygenic score pilot for heart disease begins

NHS launches innovative genomic testing project that could help revolutionise heart disease identification and prevention

The brain, the gut and the genome

We explore the link between our mental and physical health by looking at results from a recent genome-wide association study
Render of a DNA helix and Planet Earth

Flash forward: genomics in 2022

In our second end-of-year roundup, we look ahead to three areas of genomics likely to spark discussion in the coming year
3D render of cancer cells

Targeting oncogenes: a two-drug treatment

Is two better than one? We look at findings from a cancer study that explores a novel two-drug approach to treat rare ovarian cancer